Literature DB >> 3794733

Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease.

A Berardelli, J P Dick, J C Rothwell, B L Day, C D Marsden.   

Abstract

Rapid wrist flexion movements were studied in a group of 10 patients with Parkinson's disease both on and off their normal drug therapy, and were compared with the same movements made by a group of eight normal individuals. When normal subjects made movements through 60 degrees, the first agonist burst of EMG activity in the wrist flexor muscles was longer and larger than that seen in movements of 15 degrees. If a large opposing load of 2.2 Nm was added, this also increased the size and duration of the first agonist EMG burst. Although the movements made by the patients were slower than those of normals, the size and duration of the first agonist EMG burst changed with movement size and added load in the normal way. This shows that patients can produce large, long bursts of EMG activity, but that there is a failure to match these parameters appropriately to the size of movement required. The effect of levodopa therapy on the movements was not dramatic. Although patients produced faster wrist movements when on medication than when off, the change was relatively small compared with the change seen in their overall clinical rating. Changes in the velocity of movements at a single joint are not a good reflection of the overall clinical state of patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3794733      PMCID: PMC1029076          DOI: 10.1136/jnnp.49.11.1273

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.

Authors:  I T DRAPER; R J JOHNS
Journal:  Bull Johns Hopkins Hosp       Date:  1964-12

2.  Ballistic flexion movements of the human thumb.

Authors:  M Hallett; C D Marsden
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182

3.  Function of the basal ganglia as revealed by cognitive and motor disorders in Parkinson's disease.

Authors:  C D Marsden
Journal:  Can J Neurol Sci       Date:  1984-02       Impact factor: 2.104

4.  Movements not involved in posture are abnormal in Parkinson's disease.

Authors:  A Berardelli; J C Rothwell; B L Day; C D Marsden
Journal:  Neurosci Lett       Date:  1984-06-01       Impact factor: 3.046

5.  The corticomotoneurone connection is normal in Parkinson's disease.

Authors:  J P Dick; J M Cowan; B L Day; A Berardelli; T Kachi; J C Rothwell; C D Marsden
Journal:  Nature       Date:  1984 Aug 2-8       Impact factor: 49.962

6.  Duration of the first agonist EMG burst in ballistic arm movements.

Authors:  A Berardelli; J C Rothwell; B L Day; T Kachi; C D Marsden
Journal:  Brain Res       Date:  1984-06-18       Impact factor: 3.252

7.  Abnormal force--EMG relations in paretic limbs of hemiparetic human subjects.

Authors:  A Tang; W Z Rymer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-08       Impact factor: 10.154

8.  The function of the antagonist muscle during fast limb movements in man.

Authors:  C D Marsden; J A Obeso; J C Rothwell
Journal:  J Physiol       Date:  1983-02       Impact factor: 5.182

9.  Visual "closed-loop" and "open-loop" characteristics of voluntary movement in patients with Parkinsonism and intention tremor.

Authors:  K A Flowers
Journal:  Brain       Date:  1976-06       Impact factor: 13.501

10.  A physiological mechanism of bradykinesia.

Authors:  M Hallett; S Khoshbin
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more
  52 in total

1.  Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson's disease.

Authors:  Chul Hyoung Lyoo; Young Hoon Ryu; Myung Sik Lee
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

Review 2.  Motor control abnormalities in Parkinson's disease.

Authors:  Pietro Mazzoni; Britne Shabbott; Juan Camilo Cortés
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

3.  Abnormal most-rapid isometric contractions in patients with Parkinson's disease.

Authors:  M M Wierzbicka; A W Wiegner; E L Logigian; R R Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

4.  Neural correlates underlying micrographia in Parkinson's disease.

Authors:  Tao Wu; Jiarong Zhang; Mark Hallett; Tao Feng; Yanan Hou; Piu Chan
Journal:  Brain       Date:  2015-11-02       Impact factor: 13.501

5.  Characteristics of the electromyographic patterns of lower limb muscles during gait in patients with Parkinson's disease when OFF and ON L-Dopa treatment.

Authors:  M Cioni; C L Richards; F Malouin; P J Bedard; R Lemieux
Journal:  Ital J Neurol Sci       Date:  1997-08

6.  Training BIG to move faster: the application of the speed-amplitude relation as a rehabilitation strategy for people with Parkinson's disease.

Authors:  Becky G Farley; Gail F Koshland
Journal:  Exp Brain Res       Date:  2005-11-11       Impact factor: 1.972

7.  Temporal movement control in patients with Parkinson's disease.

Authors:  N Teasdale; J Phillips; G E Stelmach
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

8.  A component analysis of the generation and release of isometric force in Parkinson's disease.

Authors:  N Jordan; H J Sagar; J A Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

9.  Dopaminergic modulation of the planning phase of skill acquisition in Parkinson's disease.

Authors:  Brenda Hanna-Pladdy; Kenneth M Heilman
Journal:  Neurocase       Date:  2009-12-08       Impact factor: 0.881

10.  Coding of movement direction and amplitude in Parkinson's disease: are they differentially impaired (or unimportant)?

Authors:  D L Jones; J G Phillips; J L Bradshaw; R Iansek; J A Bradshaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.